NIH researchers' clinical trials show promising results in treating lymphoma ... pharmabiz.com Wyndham Wilson, head of NCI's Lymphoma Therapeutics Section, and colleagues conducted the trial, in which every patient received the drugs etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, and rituximab in a regimen known as ... |
